Characterizing Continuous Glucose Monitoring Prescription Patterns Between 2020 and 2024: A Retrospective Study at a Single Primary Care Facility in the United States
Journal of Diabetes Research · 2026
DOI: 10.1155/jdr/8650831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Rahma Mkuu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, Florida, USA, ufl.edu. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Practice Patterns, Physicians', Blood Glucose. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, University of Florida Gatorade Royalties, NIH HHS.
Abstract (Originalsprache)
Objective
Examine the factors associated with continuous glucose monitoring (CGM) device prescriptions in a primary care facility. Materials and Methods We conducted a retrospective study of 1476 patients with Type 1 and Type 2 diabetes receiving care at a single primary care facility between 2020 and 2024. We examined the associations between receiving a CGM prescription and demographic characteristics, health factors, de‐identified physician information, and insurance status. We conducted univariate analysis using chi‐square tests. Multivariate logistic regression models accounted for multiple factors predicting receiving a CGM prescription.
Results
The average CGM prescription rate per physician was less than 4%. Various factors were significantly associated with receiving a CGM prescription. Notably, younger patients on insulin, with Type 1 diabetes, and higher glycated hemoglobin (HbA1C) values were more likely to be prescribed a CGM device. Patients with nutritional and metabolic diseases or abnormal lab values were less likely to receive a CGM prescription.
Conclusions
Our findings are similar to those of other CGM studies, which show that CGM prescriptions are significantly higher among patients who are younger and who have Type 1 diabetes. There is a need for future studies that aim to better understand CGM prescribing decision‐making among PCPs to inform the development of targeted interventions to improve CGM prescribing rates for all eligible patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, Florida, USA, ufl.edu.
- Department of Medicine, University of Florida, Gainesville, Florida, USA, ufl.edu.
- Department of Electrical & Computer Engineering, University of Florida, Gainesville, Florida, USA, ufl.edu.
ORCID-Profile: Rahma Mkuu, Protiva Rahman, Daniela Rivero-Mendoza, William Troy Donahoo, Elizabeth Shenkman, Marcos R Lamas
Förderung
- NCI NIH HHS
- University of Florida Gatorade Royalties
- NIH HHS
- National Institutes of Health
Zitieren
APA
Mkuu, R., Rahman, P., Rivero-Mendoza, D., Donahoo, W. T., Shenkman, E., Ojo, D., & Lamas, M. R. (2026). Characterizing Continuous Glucose Monitoring Prescription Patterns Between 2020 and 2024: A Retrospective Study at a Single Primary Care Facility in the United States. Journal of Diabetes Research. https://doi.org/10.1155/jdr/8650831
Vancouver
Mkuu R, Rahman P, Rivero-Mendoza D, Donahoo WT, Shenkman E, Ojo D, et al. Characterizing Continuous Glucose Monitoring Prescription Patterns Between 2020 and 2024: A Retrospective Study at a Single Primary Care Facility in the United States. Journal of Diabetes Research. 2026. doi:10.1155/jdr/8650831
BibTeX
@article{Mkuu2026,
author = {Mkuu, Rahma and Rahman, Protiva and Rivero-Mendoza, Daniela and Donahoo, William Troy and Shenkman, Elizabeth and Ojo, Diandra and Lamas, Marcos R},
title = {Characterizing Continuous Glucose Monitoring Prescription Patterns Between 2020 and 2024: A Retrospective Study at a Single Primary Care Facility in the United States},
journal = {Journal of Diabetes Research},
year = {2026},
doi = {10.1155/jdr/8650831}
}
EUVIMED